Drugmakers are set to raise the prices of 350 drugs at the beginning of 2023.
Pfizer, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC, and Sanofi SA are among several drugmakers set to raise prices, according to healthcare research firm 3 Axis Advisors, Reuters reported.
"Drug makers have to take a harder look at calibrating those launch prices out of the gate ... so they don't box themselves into the point where in the future, they can't price increase their way back into profitability," President Antonio Ciaccia of 3 Axis Advisors told Reuters.The price rises in January aren't expected to be dramatic, with none of them going above 10%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in JanuaryDrugmakers including Pfizer Inc , GlaxoSmithKline PLC , Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.
Read more »
Pharma industry to hike prices on over 350 drugs in USDrugmakers including Pfizer, GlaxoSmithKline, Bristol Myers Squibb, AstraZeneca and Sanofi plan to raise prices in US on more than 350 unique drugs
Read more »
Pharma Giants to Hike 350+ US Drug Prices in the New Year: AnalysisResponding to a report that BigPharma will hike prices on over 350 drugs next week, actdottv said: 'Why? Because they can. Big Pharma does not care about us.'
Read more »
Oil expected to stay volatile in 2023, but the price could depend on China reopeningOil prices may not have as wide a swing in 2023 as they had in 2022, but the market will still remain volatile and risks price shocks, energy analysts say.
Read more »
Gold Price Forecast: XAU/USD clings to mild gains above $1,800 as bulls brace for 2023Gold price (XAU/USD) replicates the sluggish market conditions during early Friday, despite printing mild gains around the intraday high near $1,818 b
Read more »
$8K dive or $22K rebound? Bitcoin traders anticipate Q1 BTC price actionBTC price predictions put Bitcoin as low as $8,000 as traders diverge on Q1 2023.
Read more »